Skip to main content

Published locations for Saxagliptin, alogliptin show cardiovascular safety in randomized trials

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Saxagliptin, alogliptin show cardiovascular safety in randomized trials

User login

  • Reset your password
  • /content/saxagliptin-alogliptin-show-cardiovascular-safety-randomized-trials
  • /familypracticenews/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular
  • /internalmedicinenews/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular
  • /clinicalendocrinologynews/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show
  • /ecardiologynews/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular-safety
  • /cardiology/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular-safety
  • /endocrinology/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular-safety
  • /internalmedicine/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular-safety
  • /familymedicine/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular-safety
  • /chestphysician/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular-safety
  • /type-2-diabetes-icymi/article/77418/cad-atherosclerosis/saxagliptin-alogliptin-show-cardiovascular